Global Laparoscopic Gynecological Procedures Market by End Use (ASCs, Hospitals), by Procedure (Laparoscopic Hysterectomy, Laparoscopic Myomectomy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global laparoscopic gynecological procedure market was valued at USD 21.83 million in 2020. It is projected to grow at a compound annual rate (CAGR of 6.7%) between 2021 and 2028. The market is growing due to the increasing adoption of minimally invasive surgery, rising prevalence of gynecological conditions, and technological advances in surgery. The market was also affected by the COVID-19 epidemic, which saw many surgeries delayed or canceled in order to stop the spread of the virus. Although elective surgeries are rare, urgent gynecological and obstetric surgery are still being performed.

American Association of Gynecologic Laparoscopists, European Society of Gynaecological Endoscopy and Royal College of Obstetricians & Gynaecologists (RCOG) all stated that elective surgery for benign conditions must be delayed and priority should be given to emergency surgeries. This will allow for the use of important resources in mandatory areas.

Market growth is being driven by the increasing number of gynecological conditions such as Uterine Fibroids (UF), abnormal vaginal bleeding, cervical cancer, ovarian cysts and endometriosis. One of the most common gynecological conditions is UF. This benign tumor is made up of smooth muscle cells in the uterus. It can cause pelvic pain, severe menstrual bleeding, frequent urination, and extreme menstrual bleeding. According to a research article published by Dove Press Ltd., the prevalence estimates of uterine fibrid disease ranged from 5.4% to 23.6% depending on age. According to the American Academy of Family Physicians prevalence can be detected in as many as 80% of women within 50 years. This high patient target leads to an increase of laparoscopic procedures.

Uterine cancer is a very common gynecological disorder worldwide. It is increasing at an alarming rate. The rise in obesity has often been the driving force behind this increase. According to the American Cancer Society, Inc., approximately 66,570 new cases of uterine cancer will be diagnosed by 2021. The Canadian Cancer Society estimates that nearly 7,400 Canadian women will be diagnosed with uterine carcinoma in 2020. Cancer Research U.K. also states that uterine cancer is the fourth most common type of cancer with approximately 9,500 cases reported in 2017. The increasing prevalence of uterine cancer has resulted in an increase in laparoscopic procedures and a faster market growth.

Because they are less traumatic, minimally invasive surgery procedures are becoming more popular. These procedures are being rapidly adopted due to their ease of use and speed of recovery. This is fueling R&D in the field. A few countries also offer minimally invasive laparoscopic surgery coverage. As per the Medicare Benefits Schedule, Medicare covers up to 75% for laparoscopic procedures. Patients have a greater preference for minimally invasive surgery because of these factors.

Single-site incisional surgery has been widely adopted in laparoscopic procedures. It is replacing traditional procedures that required four to five small incisions to allow for the entrance of laparoscopic instruments. One-site incision surgery is less likely to cause infection, has better cosmetic results, faster recovery and causes less pain. According to the Journal of the Society of Laparoendoscopic Surgeons, women who have undergone single-site laparoscopic surgery report less pain afterward than those who had the traditional procedure. The market will see a rise in single-incision surgery over the next few years.

Another key driver of market growth is the rising incidence of colorectal carcinoma. People who eat low-fiber foods, including animal protein, fat and refined carbohydrates, are most likely to develop colorectal cancer. The demand for colorectal surgery has increased due to the higher risk of colorectal cancer and bladder cancer. A study published in NCBI found that colorectal cancer is fourth most common and second leading cause of death from cancer in the United States. The American Cancer Society (ACS), however, reported that colorectal cancer has increased in the United States to 101,420 in 2019.

Colorectal cancer is more common in older people, who are typically diagnosed between 65 and 74 years. According to the WHO, the global elderly population will increase from 7% in 2000 up to 16% by 2050. The American Society of Nephrology states that urologic conditions are the third most prevalent concern in the elderly population. These disorders account for approximately 47% of all physician visits. The market will be driven by the growing geriatric population over the forecast period.

Procedure Insights

Laparoscopic hysterectomy dominated the market in 2020 accounting for 48.2% of the total revenue. The market can be divided into laparoscopic hysterectomy (sacrocolpopexy), laparoscopic myomectomy (sacrocolpopexy), laparoscopic colpopexy ("sacrocolpopexy", sacrocervicopexy), etc. ), laparoscopic endometrial excision, laparoscopic adnexal (oophorectomy, salpingooophorectomy, etc. ), Laparoscopic Diagnostic Procedures (requires chromopertubation).

Laparoscopic hysterectomy, which is minimally invasive and widely used to remove the uterus, is one of the most popular procedures. This procedure offers many advantages such as a low risk of infection or blood loss and shorter hospital stays. The risks of complications after surgery are low. This procedure is also less expensive than a robotic hysterectomy. These advantages are driving its widespread adoption and thereby boosting segment growth.

Laparoscopic myomectomy is expected to have the fastest predicted CAGR. This procedure is safe and inexpensive, and it's more cost-effective than other methods. This procedure results in less blood loss and a shorter hospital stay. It also allows for faster postoperative recovery. You also have a lower risk of experiencing postoperative pain, ileus and thrombo-embolic phenomena. Laparoscopic myomectomy, which is a more effective option to traditional laparotomy, has been popularized over the past 20 years.

This procedure can be difficult in minimally invasive surgery. It requires a skilled surgical team, the right instrumentation and careful patient selection. However, laparoscopic myomectomy is not being limited to tertiary care due to the growing interest of gynecologists in laparoscopic methods. There have been advancements in surgical instrumentation, suturing materials, and some inclination by gynecologists towards laparoscopic procedures. Furthermore, technological advances, such as the increased use of robotic and laparoscopic-assisted surgery to provide quality and effective care, will add to the segment expansion in the forecast period.

End-use Insights

In 2020, the hospitals segment accounted for 57% of all revenue. Hospitals provide superior care and reimburse for certain procedures. This is further fueling the segment's growth. Hospitals are also advancing technologically. Hospitals are using technologically advanced devices to offer better treatment. These devices not only simplify treatment but also provide better, faster and more accurate results.

Hospitals see a significant increase in patients for laparoscopic procedures compared to other healthcare settings. This is due to the ease of treating any emergency that might arise during surgery and the availability of many treatment options. These factors will drive growth in the hospital segment.

The market can be divided into clinics, hospitals, Ambulatory Surgery Centers and other segments based on end use. The increase in patients with chronic conditions and the consequent rise in surgical procedures can be attributed to the growth of hospitals.

Over the forecast period, the ASCs market is expected to grow at a fastest CAGR. This segment is experiencing a high demand for outpatient surgery, an increase in minimally invasive procedures, and a cost-effective ASC-based laparoscopic procedure. These are the key factors that have driven its growth. ASCs are expected to see a decrease in post-surgical complications after minimally invasive surgery. ASCs offer several benefits to patients including a shorter procedure time and same day discharge. Because they are less invasive, most intra-abdominal surgeries can be done laparoscopically at ambulatory surgical centers. Ambulatory surgery centers are less expensive than inpatient surgeries and require a shorter hospital stay. This reduces patient spending. These factors will boost segment growth over the forecast period.

Regional Insights

North America was the dominant market, accounting for 40.72% of the global share revenue in 2020. This is due to its well-established healthcare infrastructure and the availability of skilled surgeons. It also has the launch of innovative products by key market players. The market will grow in the coming years due to increasing awareness of the benefits of laparoscopic and minimally invasive surgery. Both new and established players may be attracted by the rising healthcare spending in the United States.

According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending grew by 4.6% to USD 3.8 trillion in 2019. This represents 17.7% of the GDP. National Health spending will grow at an average annual rate of 5.4% between 2019 and 2028 to reach USD 6.25 trillion by 2028. Many government and non-governmental bodies have increased funding for healthcare to support technological advances in surgery and other areas.

Healthcare finance by the state and local governments has increased to 4.1% in 2017, from 3.8% in 2016. These are all indicators that the U.S. market will experience significant growth during the forecast period. Asia Pacific's market is dominated by China, Japan and India. In terms of revenue share in 2020, China was the dominant market in APAC. China's market is driven by rising disposable income and a rapidly growing geriatric population.

China Population and Development Research Center estimates that approximately 350.0 million Chinese will reach 65 by 2050. According to the WHO, China will have approximately 400 million people 60 and above by 2020. There will also be around 100 million people over 80 years old by 2020. Affordable devices, increased mergers and acquisitions, as well as government initiatives to improve healthcare services are all key factors. The country's government has made substantial investments in basic health insurance for all citizens.

Market Share Insights & Key Companies

To strengthen their position in the global market, key players participate in strategies such as mergers and acquisitions, partnerships, new product launches, and partnership. Medtronic, an innovator in surgical Artificial Intelligence, digital education, training and data analytics, acquired Digital Surgery in February 2020. The acquisition will improve its robotic-assisted surgical platform and provide AI/data analytics in laparoscopic procedures.

Ethicon launched ENSEALX1 Curved Jaw Tie Sealer in June 2021. This advanced laparoscopic bipolar energy device provides stronger sealing, better grip to tissues and increases procedural efficiency. It can be used for colorectal, gynecological and thoracic surgery. The following are some of the major players in the global market for laparoscopic gynecological services:

• Medtronic

• Stryker Corp.

• Karl Storz SE & CO. Kg

• Johnson and Johnson

• Olympus Corp.

• CONMED Corp.

• B. Braun Melsungen AG

• The Cooper Companies, Inc.

• Richard Wolf GmbH

• Microline Surgical

• Welfare Medical Ltd.

• Intuitive Surgery

• Shenzen Mindray Bio Medical Electronics Co., Ltd.

Up Market Research published a new report titled “Laparoscopic Gynecological Procedures Market research report which is segmented by End Use (ASCs, Hospitals), by Procedure (Laparoscopic Hysterectomy, Laparoscopic Myomectomy), By Players/Companies Medtronic, Shenzen Mindray Bio Medical Electronics Co Ltd, B Braun Melsungen AG, CONMED Corp, Stryker Corp, Richard Wolf GmbH, Johnson and Johnson, Intuitive Surgical, Welfare Medical Ltd, Microline Surgical, Karl Storz SE & CO Kg, Olympus Corp, The Cooper Companies Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Laparoscopic Gynecological Procedures Market Report Segments:

The market is segmented by End Use (ASCs, Hospitals), by Procedure (Laparoscopic Hysterectomy, Laparoscopic Myomectomy).

Laparoscopic Gynecological Procedures Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Laparoscopic Gynecological Procedures Market

Overview of the regional outlook of the Laparoscopic Gynecological Procedures Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Laparoscopic Gynecological Procedures Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Laparoscopic Gynecological Procedures Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. ASCs

                2. Hospitals

                1. Laparoscopic Hysterectomy

                2. Laparoscopic Myomectomy

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Laparoscopic Gynecological Procedures Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Laparoscopic Gynecological Procedures Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.